Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HS-10374 tablets in adults with mild to moderate plaque psoriasis
CTR20251043Phase 2Completed
- Sponsor
- Changzhou Hengbang Pharmaceutical
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10374 in plaque psoriasis, sponsored by Changzhou Hengbang Pharmaceutical. Started Apr 2025; status: completed.
02
Drugs
HS-10374
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20251043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251043.